Johnson & Johnson (JNJ) Interest Coverage Ratio (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Interest Coverage Ratio came in at 23.39 in Q1 2026, down 22.8% year-on-year from 30.3 in Q1 2025, and down 75.05% quarter-over-quarter from 93.75 in Q4 2025.

Johnson & Johnson (JNJ) Interest Coverage Ratio (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Interest Coverage Ratio across 18 years of filings, most recently posting 23.39 for Q1 2026.

  • Interest Coverage Ratio for Q1 2026 came in at 23.39, down 22.8% year-over-year; the trailing twelve-month figure through Mar 2026 was 38.6 (up 45.78% YoY), and the FY2025 annual result was 41.12, up 47.72% from the prior year.
  • Interest Coverage Ratio came in at 23.39 for Q1 2026 at Johnson & Johnson, down from 93.75 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 435.2 in Q2 2022 to a low of 21.58 in Q2 2025.
  • The 5-year median for Interest Coverage Ratio is 29.9 (2023), against an average of 72.04.
  • Across the five-year window, Interest Coverage Ratio jumped 315.73% in 2022 and tumbled 93.8% in 2023, its largest moves.
  • Johnson & Johnson's Interest Coverage Ratio stood at 103.9 in 2022, then grew by 20.17% to 124.85 in 2023, then plunged by 78.96% to 26.27 in 2024, then surged by 256.88% to 93.75 in 2025, then tumbled by 75.05% to 23.39 in 2026.
  • The last three Interest Coverage Ratio figures came in at 23.39 (Q1 2026), 93.75 (Q4 2025), and 28.71 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Gsk 92,134,969.93 Bn 92,134,964.97 Bn 7.76 Bn -13.73
2 Eli Lilly 1,027.45 Bn 1,022.17 Bn 16.22 Bn -
3 Johnson & Johnson 559.08 Bn 537.03 Bn 15.96 Bn 23.39
4 AbbVie 394.75 Bn 385.40 Bn 10.78 Bn -
5 Merck 295.12 Bn 289.47 Bn 12.09 Bn -
6 Amgen 186.65 Bn 174.61 Bn 5.87 Bn 4.06
7 Gilead Sciences 159.22 Bn 151.50 Bn 5.52 Bn 10.78
8 Pfizer 146.00 Bn 133.23 Bn -1.21 Bn -
9 Bristol Myers Squibb 113.22 Bn 102.77 Bn 8.07 Bn -
10 Novartis Ag 108.02 Bn 107.33 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 23.39
Dec 28, 2025 93.75
Sep 28, 2025 28.71
Jun 29, 2025 21.58
Mar 30, 2025 30.30
Dec 29, 2024 26.27
Sep 29, 2024 26.10
Jun 30, 2024 23.96
Mar 31, 2024 38.12
Dec 31, 2023 124.85
Oct 1, 2023 29.90
Jul 2, 2023 26.79
Apr 2, 2023 26.96
Jan 1, 2023 62.80
Oct 2, 2022 103.90
Jul 3, 2022 102.08
Apr 3, 2022 435.20
Oct 3, 2021 330.30
Jul 4, 2021 155.05
Apr 4, 2021 104.68